Myofibrillar myopathies are a group of muscle disorders characterized by the disintegration of skeletal muscle fibers and formation of sarcomeric protein aggregates. All the proteins known to be involved in myofibrillar myopathies localize to a region of the sarcomere known as the Z-disk, the site at which defects are first observed. Given the common cellular phenotype observed in this group of disorders, it is thought that there is a common mechanism of pathology. Mutations in filamin C, which has several proposed roles in the development and function of skeletal muscle, can result in filamin-related myofibrillar myopathy. The lack of a suitable animal model system has limited investigation into the mechanism of pathology in this disease and the role of filamin C in muscle development. Here, we characterize stretched out (sot), a zebrafish filamin Cb mutant, together with targeted knockdown of zebrafish filamin Ca, revealing fiber dissolution and formation of protein aggregates strikingly similar to those seen in filamin-related myofibrillar myopathies. Through knockdown of both zebrafish filamin C homologues, we demonstrate that filamin C is not required for fiber specification and that fiber damage is a consequence of muscle activity. The remarkable similarities in the myopathology between our models and filamin-related myofibrillar myopathy makes them suitable for the study of these diseases and provides unique opportunities for the investigation of the function of filamin C in muscle and development of therapies.
INTRODUCTION
Myofibrillar myopathies (MFMs) are a group of muscle disorders characterized at the cellular level by the breaking down, or dissolution, of muscle fibers. This disintegration of the fiber is accompanied by the accumulation of muscle protein aggregates. Clinically, MFMs can present with a diverse range of symptoms and can affect both proximal and distal muscle groups, although in some cases one muscle group is predominantly affected. The skeletal muscle defects are frequently accompanied by failure of the respiratory muscles and in some cases cardiac complications. Causative mutations for MFM have been identified in desmin (1-4), aB-crystallin (5,6), myotilin (7), ZASP (Z band alternatively spliced PDZ-containing Protein), also known as LIM domain-binding protein 3 (8) , BCL2-associated athanogene 3 (BAG3) (9) and filamin C (10 -12) . However, the genetic basis for many MFMs remains to be determined.
All of the proteins implicated in MFM are detected at the Z-disk, a region of the sarcomere that provides an important structural linkage in the transmission of tension and contractile forces along the muscle fiber and has a role in sensing muscle activity and signal transduction. Therefore, it is not surprising that electron microscopy studies performed on MFM muscle biopsy samples have identified the initial defect in MFM as dissolution of the muscle fiber, starting at the Z-disk (13) . Mutations in the different MFM proteins result in highly similar pathological features at the cellular level, suggesting a common mechanism of action. However, the mechanisms by which mutations in these proteins result in disease are not understood.
Filamin-related MFM is a subtype of MFM resulting from mutations in filamin C (FLNC, also referred to as filamin 2, g-filamin, and actin-binding protein 280). FLNC was first implicated in MFM in 2005 with the identification of a missense mutation in a German family presenting symptoms similar to those seen in other MFM patients (10) . Since this initial discovery, additional MFM causing FLNC mutations have been identified with all of the affected families demonstrating autosomal dominant inheritance with the age of * To whom correspondence should be addressed. Tel: +61 399024629; Fax: +61 399055613; Email: robert.bryson-richardson@monash.edu (R.J.B.-R.); Tel: +61 399029602; Fax: +61 399029729; Email: peter.currie@monash.edu (P.D.C.) onset ranging from 24 to 60. Presentation is highly consistent between the different families identified, with proximal muscles being predominantly affected and patients frequently developing respiratory muscle weakness. More recently, FLNC mutations were identified as a cause of distal myopathy (14) with a haploinsufficient form of FLNC distal myopathy subsequently described, suggesting that the levels of FLNC may be critical (15) .
Filamin C is a member of the Filamin family of actin-binding proteins and is expressed predominantly in skeletal and cardiac muscle (16) . The vast majority of FLNC is localized at the Z-disk, where it is thought to interact with other sarcomeric proteins, such as actin, myopodin and myotilin, and maintain the structural integrity of the sarcomere (17) . A small fraction of FLNC localizes at the costamere, the sites at which the Z-disk attaches to the sarcolemma, where FLNC interacts with Cbl-associated protein, b1-integrin and g-and d-sarcoglycans (17) . FLNC therefore connects the Z-disk to the sarcolemma and the extracellular matrix through integrin and the dystrophin-associated protein complex, providing both a structural linkage and a mechanism for signaling from the sarcolemma to the Z-disk (17) .
Muscle pathology in filamin-related MFMs is characterized by the formation of large cytoplasmic protein aggregates containing Z-disk and other muscle proteins, including FLNC, desmin, dysferlin, aB-crystallin, myotilin, dystrophin, xin and g-and d-sarcoglycans (10) (11) (12) 18) . Interestingly, a-actinin, a protein found specifically in the Z-disk, and titin, a protein found in all compartments of the sarcomere including the Z-disk, have never been reported in these deposits. This suggests that in filamin-related MFMs and other MFMs, a specific function of the Z-disk is disrupted (11) . Several possible functions for filamin C have been postulated, including a structural role in the Z-disk (19) , providing a link between the Z-disk and the sarcolemma at the site of the costamere, signaling through interaction with sarcoglycans and integrins (17) , and specification of muscle fate (20) . It remains unclear if disruption of one or all of these functions is necessary to cause filamin-related MFM or, as has been previously suggested (21) , it is the gradual accumulation of mutant protein and sequestration of filamin C-binding partners in the cytoplasm that results in fiber dissolution.
To investigate filamin C function, a mouse knockout of Flnc, lacking the last eight exons including the dimerization domain together with the sarcoglycan and FATZ interacting domains, was generated (20) . These mice demonstrate severe muscle defects and die as a result of respiratory failure soon after birth. A reduction in the number of muscle fibers, with no increase in apoptosis, suggested a role for FLNC in fiber differentiation (20) . Examination of the muscle fibers with electron microscopy revealed that the majority of fibers demonstrated normal sarcomeric appearance. However, a small but significant number of the fibers showed a rounded appearance with centrally located nuclei and overlapping of thin and thick filaments together with the loss of distinct Z-disks (20) . This led to the suggestion that FLNC plays an important role in the maintenance of muscle structure and in the differentiation of myoblasts, but not in the process of sarcomerogenesis.
The generation of a mouse model is a major advance in the investigation into the biology of MFM. However, a major disadvantage of the mouse model is that it is not possible to observe the failure of the muscle fibers and the sequence of events in the pathology. Additionally, due to the severity of the respiratory defect in these mice, we cannot follow the fate of the muscle cells in which fibers have undergone dissolution. More recently, the medaka mutant zacro was characterized. The zacro mutant is as a result of a mutation in one of two medaka homologues of FLNC and displays skeletal muscle fiber degeneration and an enlargement of the heart. However, zacro does not present with either dissolution of myofibrils or protein accumulation, the key features of MFM. There is therefore a need for further development of animal models to investigate filamin-related MFM and the role of filamin C in muscle development and function. Here, we characterize zebrafish models of filamin-related myopathy that display fiber dissolution and formation of sarcomeric protein aggregates, phenotypes that are remarkably similar to the human condition, and use these models to investigate the role of filamin C.
RESULTS

Stretched-out mutant embryos display slow muscle fiber defects
The stretched-out (sot) mutant was identified in a genetic screen for mutants affecting muscle and motor neuron development (22) . In contrast to the previously described zebrafish dystrophic muscle mutants (23) (24) (25) (26) , muscle fibers in the sot mutant break along the length of the fiber, rather than detach from one end [ Fig. 1A and B, (22) ]. The severity of the phenotype is varied with some mutants having all the fibers within an individual somite affected while others have only a single fiber affected. Immunohistochemistry of both slow and fast myosin revealed disruption of the slow muscle fibers, with the fast muscle being unaffected, confirming the observation made by Birely et al. (22) . As previously reported, the sot phenotype is transitory [ Fig. 1C , (22) filamin Cb is mutated in the sot mutant Genetic mapping was performed to identify the gene mutated in sot. Two DNA pools for use in bulk segregant analysis were created from 44 mutants and 44 siblings as identified by slow myosin antibody labeling at the 26-somite stage. One hundred and ninety-two SSLP markers from the G4 mapping panel (27) were tested on these pools, revealing linkage of the mutation to markers z21636, z10164, z11876, z17278 and z27918 on linkage group 4. Analysis of these markers on DNA extracted from individual embryos was then used to narrow down the region containing the mutation to a 3.48 Mbp region between the markers z10164 and z11876 ( Fig. 2A) . This region contained zebrafish FLNC homologues. Sequencing of the flncb coding region in a sot mutant identified an A to T transversion in exon 30 (c.5056A.T; ENSDART00000026492) resulting in the creation of a premature stop codon (Fig. 2B) . To confirm the association of this mutation with the phenotype, 14 sot mutants and 21 unaffected siblings were sequenced. All 14 mutants contained an A to T transversion, while 7 out of the 21 siblings were homozygous for the wild-type allele A and the remaining 14 siblings were heterozygous at that locus (Fig. 2B ).
To determine whether flncb mRNA levels are affected in the sot mutant, in situ hybridization was performed using a probe specific to the 3 ′ UTR of flncb. Transcript levels were greatly reduced in sot mutants, compared with wild-type embryos, indicative of nonsense-mediated decay. To further confirm that the identified mutation in flncb is the cause of the sot phenotype, a flncb splice-site-targeting morpholino was injected into wild-type embryos along with the dye Cascade Blue. At the 26-somite stage, all morpholino-injected embryos, identified by the presence of Cascade Blue, contained broken slow muscle fibers, phenocopying the sot mutant (Fig. 2D , n ¼ 21). To determine the efficacy of the morpholino, RT -PCR was performed on a pool of flncb morphants selected by the presence of the blue dye. In flncb morphants, a complete loss of correctly spliced transcript was seen along with the presence of mis-spliced splice variants when compared with uninjected controls (Fig. 2E ).
filamin C expression during zebrafish development
Searching of the Ensembl genome database identified the presence of a second FLNC homologue in zebrafish, filamin Ca (flnca). To investigate the temporal and spatial expression of flncb, the gene mutated in sot and flnca (the second zebrafish FLNC homologue), we performed in situ hybridization at the 12-somite, 18-somite, 24-somite, 28-somite and 34-hpf stages of development. At the 12-somite stage, expression of flnca is evident in presomitic adaxial cells, the slow muscle precursor cells. flnca expression remains specific to the migrating slow muscle population at the 18-somites stage and in the lateral slow muscle population and muscle pioneer cells at the 24-somite stage. By 34 hpf, flnca becomes restricted to only the muscle pioneer cells (Fig. 3A-O) .
Examination of flncb expression at the 12-somite stage demonstrated strong expression throughout the slow and fast muscle domains, including strong expression in the presomitic adaxial cells. flncb is expressed in both the slow and fast muscle populations at the 18-and 24-somite stages before becoming restricted to fast muscle at the 34 hpf stage ( Fig. 3P-AD) .
To determine the evolutionary relationship of the zebrafish filamin C proteins, a maximum likelihood phylogram was generated using filamin C sequences from human, mouse, zebrafish, medaka and Drosophila (Fig. 4A) . The tree identifies a duplication of filamin C in the teleost lineage. The analysis also demonstrates that zebrafish Flnca is more closely related to medaka Flnca1/2 (mutated in the medaka zacro mutant) and zebrafish Flncb to medaka Flnc2/2. against the human FLNC protein was used to validate the efficacy of both morpholinos. The target epitope is conserved in both Flnca and Flncb proteins and therefore it was expected that the FLNC antibody would bind to both Flnca and Flncb proteins. High levels of Flnc were detected at the myosepta and a weak signal in the muscle fibers in slow muscle cells in wild-type embryos, sot mutants and flnca morphants. The flnca+b double morphants, however, had a complete loss of Flnc staining (Supplementary Material, Fig. S1 ). flnca morphants (Fig. 4C) were found to have a phenotype similar to the sot mutant ( Fig. 4B) with failure of slow muscle fibers and formation of Myosin-containing balls at the myosepta. Similar to the sot mutant, this phenotype is sporadic and restricted to the slow muscle. Morpholino knockdown of both flnca and flncb produces a very severe muscle phenotype with almost all of the slow muscle fibers affected in each somite (Fig. 4D) . The severity of the sot mutant, flnca and flnca+b double morphant slow muscle phenotypes was assessed by counting the number of affected fibers per embryo at different stages of development (Fig. 4E ). Both sot mutants and flnca morphants showed a mild transitory phenotype only evident between 24-somite and the 32-somite stages (Supplementary Material, Figs S3 and S4). To assess the fate of broken slow muscle fibers in the sot mutants, the number of slow muscle fibers was counted in wild-type and genotyped sot mutants at the 34 hpf stage. Fiber count experiments revealed no significant difference in the number of slow muscle fibers at the 34 hpf stage between wild-type embryos and genotyped sot mutants (wildtype 21.7 + 0.0640 SEM, n ¼ 10 genotyped sot mutant 21.5 + 0.104 SEM, n ¼ 10; P . 0.05).
In contrast to the sot and flnca morphant phenotype, the flnca+b double-morphant phenotype was evident at the 22-somite stage (Supplementary Material, Fig. S5) , with a significant increase in broken slow muscle fibers at the 24-, 26-and 32-somite stages. Unlike sot mutants or flnca morphants, which appear to recover by 34 hpf, flnca+b double morphants show considerable slow muscle fiber damage at this stage. Loss of both filamin C isoforms results in failure of both the slow and fast muscle fibers Despite expression of flncb in the fast muscle, sot mutants do not display fast muscle defects. To investigate the role of Flnca in rescue of the fast muscle in sot mutants, the integrity of the fast muscle in flnca+b double morphants was examined using a fast muscle antibody (Fig. 5 ) and an antibody that recognizes both, slow and fast muscle (Fig. 5 and Supplementary Material,  Fig. S5 ). Using both these markers, flnca+b double morphants demonstrated severe fast muscle defects at the 48 hpf stage.
Filamin C is not necessary for fiber specification but is essential for the maintenance of fiber integrity following the onset of contraction
To examine the role of filamin C in fiber differentiation, the number of slow muscle fibers was counted in sot mutants prior to the onset of fiber failure (22-somite; Fig. 1D ). Embryos from a cross between two sot heterozygotes were fixed at the 22-somite stage, stained with the slow myosin heavy chain antibody and genotyped. There was no significant difference in the number of slow muscle fibers per somite in the first 10 somites between wild-type and genotyped sot mutant embryos (wild-type 20.38 + 0.0461 SEM, n ¼ 10, sot 20.28 + 0.0661 SEM, n ¼ 10, P . 0.05). We also investigated if loss of both FLNC homologues affects fiber differentiation. flnca+b double morphants were anesthetized at the 18-somite stage to prevent fiber disintegration and the number of slow muscle fibers was counted in anesthetized morphants at the 22-somite stage. Similar to the sot mutant, there was no significant difference in the average number of slow muscle fibers per somite between wild-type and flnca+b double embryos (wild-type 20.38 + 0.0461 SEM, n ¼ 10, flnca+b double morphant 20.36 + 0.0532 SEM, n ¼ 6; P . 0.05). and slow muscle domains (solid arrowhead), including the presomitic adaxial cells. Expression remains in both fast and slow muscle at 18-, 24-and 28-somite stages before becoming restricted to the fast muscle by 34 hpf when expression in the slow muscle cells is lost, as seen by the gap in expression in the slow muscle pioneer cells (arrow with asterisk) and lateral slow muscle layer (solid arrows). flncb is also expressed in the heart as seen at the 24-somite stage (hollow arrow).
To determine whether muscle contraction affected manifestation of the sot phenotype, embryos from a cross between two sot heterozygotes were exposed to the muscle relaxant Tricaine at the 22-somite stage and stained with the slow myosin antibody F59 at the 26-somite stage. It was found that of the 27 embryos not exposed to Tricaine, 7 embryos presented the sot phenotype. Of the 33 embryos exposed to Tricaine at the 22-somite stage, no embryos displayed broken fibers, as seen in sot mutants. A P-value of 0.0068 was obtained using the Chi-square test with Yates correction demonstrating that the observed association between the presence of Tricaine and the absence of the sot phenotype is significant.
The sot mutant, flnca and flnca1b morphant phenotypes are strikingly similar to MFM A characteristic of MFM is the mis-localization and aggregation of sarcomeric proteins. To examine sarcomeric protein localization, immunohistochemistry was performed on sot mutant embryos, flnca morphants and flnca+b double morphants, using antibodies against Myosin, Actin, Actinin and Desmin. In wild-type sibling or un-injected embryos, Myosin, Actin, Actinin and Desmin were found to localize in a perfect striated pattern in the sarcomere (Figs 6A-D, I-L, Q-T and 7A -D, M -P). In intact fibers of sot mutants, flnca morphants and flnca+b double morphants, the localization of these proteins was indistinguishable from that of the controls (Figs 6E -H, M -P, U -X and Fig. 7A -D, M -P) . However, where the fiber had failed and the Myosin striation pattern was lost, the Actin (Fig. 6H) , Actinin (Figs 6P and 7H, and L) and Desmin striation patterns were lost. Furthermore, in all three conditions, aggregates of Myosin were evident at the ends of the muscle cell. These aggregates were positive for Desmin labeling (Figs 6X and 7T and X), but were not positive for Actin and Actinin antibody labeling, demonstrating that these proteins are absent from the aggregates.
DISCUSSION
In this study, we present sot, a novel zebrafish model of filamin-related MFM which results from a nonsense mutation in flncb, one of the two zebrafish FLNC homologues. A premature stop codon in exon 30 causes loss of the C-terminal half of the protein, including the dimerization and integrin-binding domains, resulting in nonsense-mediated decay of the transcript. Morpholino knockdown of flncb phenocopies the sot phenotype, suggesting that Flncb is nonfunctional in sot mutants (Figs 1 and 2) . The sot phenotype is very specific both temporally and spatially. Slow muscle fibers appear to dissolve, and aggregates of myosin form, only between the 24-somite and 32-somite stages, after which the slow muscle appears completely normal (Fig. 1) . Loss of Flnca also results in a transitory, mild and sporadic slow muscle phenotype. Loss of both FLNC homologues, however, results in failure of the majority of slow muscle fibers (Fig. 5) . The mild phenotype resulting from the loss of either isoform compared with the very severe phenotype resulting from the loss of both isoforms demonstrates that Flnca and Flncb are functionally redundant, and that it is the total level of Flnc expression that is critical for fiber maintenance, rather than expression of either isoform. This identification of a dosage sensitivity for Flnc in the zebrafish correlates with the recent identification of a haploinsufficient form of filamin myopathy (15) .
The recovery of fibers in sot coincides with the transition from Flncb to Flnca as the major slow muscle isoform. This suggests that as the level of Flnca increases, it becomes sufficient not only to prevent failure of newly forming fibers, but also to protect existing fibers. The proposal that, as a key component required for muscle integrity, filamin C could insert into existing sarcomeres, in order to prevent damage occurring, as we are suggesting Flnca does in the rescue of the sot phenotype, is supported by experiments demonstrating the dynamic nature of Z-disk components. Using fluorescence recovery after photobleaching approaches in both in vitro culture systems (28) and, more recently, in the zebrafish (29) , it has been demonstrated that the Z-disk components are dynamic with constant exchange between bound and cytoplasmic proteins in healthy muscle. Our analysis of slow muscle fibers in the sot mutant after the phenotypic window reveals no difference in fiber number compared with unaffected siblings. This suggests that either formation of new muscle fibers occurs, or Flnca is able to restore fiber integrity in the damaged muscle. The possibility that expression of functional Filamin C could restore fiber numbers in damaged tissue in addition to preventing further fiber failure has significant therapeutic implications for the treatment of MFM.
Our analysis of the flnca morpholino-injected embryos identifies a similar transient phenotype in the slow muscle to that identified in sot (Fig. 5) , which cannot be explained by the expression of flncb, which is decreasing in the slow muscle at the time. Similarly, we do not see a phenotype in the fast muscle of sot mutants, despite Flncb being the only isoform expressed in the fast muscle. We therefore hypothesize that the loss of one of the Flnc proteins results in the upregulation of the other. Examination of the phenotype in embryos injected with flnca and flncb morpholinos confirms this hypothesis, with a phenotype evident in the fast muscle and a failure of the slow muscle to recover. This identifies the presence of a signaling pathway within the muscle sensitive to the levels of FLNC.
Analysis of the mouse Flnc knockout suggested a role for FLNC in the specification of primary muscle fibers (20) . Our analysis of the sot mutant prior to the onset of muscle failure identified no reduction in the number of slow muscle fibers. Similarly, the prevention of contraction in embryos lacking either one or both forms of Flnc prevented fiber failure. These results demonstrate that Flnc is not required for muscle specification or fiber assembly, but is required for fiber integrity during muscle contraction.
Most MFM, including filamin-related MFM, are caused by dominant mutations that result in late-onset disease, which can be difficult to work with in animal models. The Flnc loss of function mouse model exhibits many of the symptoms of MFM, but the severity of the phenotype, resulting in death minutes after birth and the inability to visualize muscle development in utero, has hampered investigation in this system. The early manifestation of Flnc deficiency in the zebrafish therefore provides a useful system to analyze fiber dissolution and the progression of pathology. These models also display a similar trend in protein accumulation to that observed in filamin-related MFM patients muscle biopsy samples with positive immunoreactivity for the Z-disk protein Desmin and lack of immunoreactivity for a-Actinin and a-Actin. The redundancy in Flnc in zebrafish provides both a mild and transient model of MFM and a severe model of MFM. It has been suggested that the progressive, late-onset, nature of filaminrelated MFM results from a reduction in FLNC function commensurate with the increasing sequestration of FLNC-binding partners by mutant FLNC in the cytoplasm. The highly similar, but early-onset, phenotype of the sot mutant, flnca morphant and flnca+b double morphant could therefore be explained by the immediate loss of Flncb, Flnca, or Flnca and Flncb, respectively, resulting in the same effect on the muscle as the progressive loss of FLNC in filamin-related MFM. Importantly, the striking similarity of the phenotype Figure 6 . Localization of sarcomeric proteins in the sot mutant. Immunohistochemistry revealed normal striated localization of Myosin, Actin, Actinin and Desmin in wild-type sibling (WT sib) embryos at the 26-somite stage (A -D, I-L, Q-T). In intact fibers of sot mutants (arrows), Myosin, Actin, Actinin and Desmin display a normal striated pattern (E-H, M -P, U-X). However, in the affected fibers in the sot mutant (arrowheads), myosin was found to form aggregates at the somitic boundaries and the Desmin, Actin and Actinin striation patterns are lost from the fibers. The aggregates were found to contain Desmin (U-X) but lack Actin and Actinin (arrowheads, E -G, I-K). (D), (H), (L), (P), (T) and (X) are single fiber views of their respective panels to the left.
in the zebrafish to that of filamin-related MFM makes these zebrafish models an excellent system to study the mechanism of pathology and potential therapies.
MATERIALS AND METHODS
Fish care
Fish strains were maintained using standard methods as previously described (30) . The wild-type strains TE and WIK were obtained from the Tübingen Stock Collection (ZIRC) and the sot mutant was obtained from the laboratory of Professor Michael Granato. Embryos were staged according to Kimmel et al. (31) . All animal work was approved by the Monash Animal Ethics Committee in accordance with the care and use of animals for scientific purposes. Fish were anesthetized using Tricaine methanesulfonate (3-amino benzoic acidethylester, Sigma) at a final concentration of 0.16% in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl, 0.33 mM MgSO 4 in H 2 0).
Mapping and genotyping
Bulk segregant analysis was performed on sot mutants on the Tu and WIK background, using the G4 and H2 SSLP mapping panels (27) . The forward primer 5 ′ -ACCAGATACACACGC ATCCA-3 ′ and the reverse primer 5 ′ -CTGCATTCTCCACC ACATCCACATCCAGCTCCGCTCCATCTGGAGTTGACA CTTTGCAAGTGACCTTCCCCT-3 ′ , specific to exon 30 of flncb, were used to amplify the region containing the mutation and the restriction enzyme Kpn1 (NEB) was used to perform genotyping digests. The allele-specific PCR KASP technology (Kbioscience) was also used for genotyping: ACTTTGCAAG TGACCTTCCCCTT and ACTTTGCAAGTGACCTTCCCC TA (minus proprietary tail information).
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde overnight at 48C, except for use in desmin staining, where embryos were fixed in 2% trichloroacetic acid for 3 h at room temperature. Post-fixation embryos were washed in PBST [1× PBS, 0.1% Tween 20 (Sigma)] and permeabilized by placing them in prechilled acetone for 7 min at 2208C. Embryos were then washed in PBST and incubated in the appropriate primary antibody. The primary antibodies used were anti-actin (Sigma, 1:100), anti-actinin (Sigma, 1:100), anti-slow myosin (F59; DSHB, 1:10), anti-myosin (A4.1025; DSHB, 1:10), anti-fast myosin (F310; DSHB, 1:10), anti-filamin C (Sigma, 1:100) and anti-desmin (Sigma, 1:100). Alexa Fluor-488 and Alexa Fluor-546 secondary antibodies (Molecular Probes) were used at 1:150. Embryos were imaged using the Zeiss LSM 710 confocal and maximum intensity projections were obtained using Fiji (http://fiji.sc).
Whole-mount in situ hybridization
Digoxygenin riboprobes were generated as previously described (30) . The flncb riboprobe was generated by amplifying and cloning 996 bp of flncb 3 ′ UTR from genomic DNA, using the forward primer 5 ′ -TACGTTTGCATACGCTTCCA-3 ′ and the reverse primer 5 ′ -AATATGCCAGCACAGTTTTACA-3 ′ . The flnca riboprobe was synthesized by amplifying and cloning 579 bp of flnca exon 22 from genomic DNA, using the forward primer 5 ′ -ACCAGGACTGAAGGGTGGTA-3 ′ and the reverse primer 5 ′ -GGCTCAACTCCTGGTCCATA-3 ′ . In situ hybridization was then performed as follows. Embryos were fixed in 4% paraformaldehyde (PFA) overnight, progressively washed into 100% methanol and stored at 2208C. Dehydrated embryos were progressively rehydrated into PBS containing 0.1% Tween 20 (PBST) prior to hybridization. Embryos were digested with proteinase K (10 mg/ml) for 0.5-3 min, fixed with 4% PFA for 20 min at room temperature (RT) and then washed twice for 5 min each with PBST. The embryos were then incubated for a minimum of 2 h at 658C in 200 ml pre-hybridization buffer (50% formamide, 5× SSC, 500 mg/ml yeast RNA, 50 mg/ml heparin and 0.1% Tween-20 brought to pH 7.0 with 1 M citric acid). Probes were added at 0.1-0.5 mg/ml in pre-hybridization buffer and incubated at 658C overnight. The next day samples were washed with 100% post-hybridization buffer (PHB; 50% formamide, 5× SSC and 0.1% Tween-20) for 5 min at 658C followed by four, 15 min, washes of 75%PHB/25% 2× SSC, 50%PHB/50% 2× SSC, 25%PHB/75% 2× SSC and 100% 2× SSC, respectively, at 658C. The embryos were then washed twice for 30 min in 0.2% SSC at 658C before being sequentially washed for 10 min at RT in 75% 0.2× SSC/25% PBST, 50% 0.2× SSC/ 50% PBST, 25% 0.2× SSC/75% PBST and 100% PBST, respectively. The embryos were then incubated at RT in sheep block (2% sheep serum, 2 mg/ml BSA in PBST) for at least 2 h followed by a 48C overnight incubation with pre-absorbed anti-DIG antibody (Roche) at 1/10000 dilution in sheep block. The embryos were washed with PBST six times for 15 min each at RT and then washed into staining buffer (100 mM Tris, pH 9.5, 50 mM MgCl 2 , 100 mM NaCl and 0.1% Tween-20) for a further three 5 min washes. The embryos were developed using a 1/50 dilution of NBT/BCIP solution (Roche) in staining buffer. Once embryos were appropriately developed, they were washed twice for 5 min each in PBST and fixed for 20 min at RT with 4% PFA. The 4% PFA was replaced with PBST and stained embryos were imaged whole or paraffin embedded (32) and sectioned at 8 mM thickness.
cDNA synthesis and RT -PCR RNA was extracted from zebrafish embryos using TRIzol w reagent (Invitrogen) and treated with DNAse (Promega) to remove genomic DNA. The superscript III first-strand synthesis kit (Invitrogen) was used to synthesis cDNA and Go-taq MasterMix (Promega) was then used for RT-PCRs, as per manufacturers protocol. Primers used were: b-actin forward primer 
Morpholino microinjection
All antisense morpholino oligonucleotides were obtained from Gene Tools and co-injected with Cascade Blue labeled dextran (Molecular Probes) at 0.01 mg/ml. For flncb knockdown, a single splice targeting morpholino was used (GAGTTTTCTA ATGGCCCTTACCTGC) at a concentration of 0.25 mM and, for flnca knockdown, a translational blocking morpholino was used (CATGGTGGGACTGCTGCTTTTATAC) at a concentration of 0.2 mM. The embryos were sorted for Cascade blue labeling prior to analysis.
Phylogenetic tree
Filamin C protein sequences from human (ENSP00000344002), mouse (ENSMUSP00000087958), zebrafish (ENSDARP00000 046217 and ENSDARP00000024947), medaka (ENSORLP00 000005322 and partial sequence ENSORLP00000024724), and fruit fly Filamin (FBpp0088478) were aligned using ClustalX. All positions containing gaps and missing data were eliminated and a maximum likelihood tree was calculated from the alignment and bootstrap values obtained from 1000 repetitions using the Jones-Taylor-Thornton (JTT) model. There were a total of 1484 positions in the final data set. Evolutionary analyses were conducted in MEGA (33) .
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
